OOIR: Observatory of International Research

Papers

(The H4-Index of Cancer Medicine is 42. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Molecular profiling of colorectal cancer in a genetically admixed Hispanic population	372
Racial and ethnic disparities in mortality among World Trade Center Health Registry enrollees with post‐9/11 cancer	209
Issue Information	140
Effects of FABP5 Expression on Clinicopathological and Survival Characteristics in Digestive System Malignancies: A Systematic Review and Meta‐Analysis	112
Impact of Body Image Perception on Behavioral Outcomes in Chinese Adolescent and Young Adult Survivors of Sarcoma	110
Issue Information	99
Physical Activity Patterns According to Demographic, Social, and Clinical Correlates Among Breast Cancer Survivors	93
Risk of recurrence after neoadjuvant chemotherapy and transoral robotic surgery in patients with oropharynx cancer that avoid adjuvant radiation	93
Oil blotting paper for formalin fixation increases endoscopic ultrasound‐guided tissue acquisition‐collected sample volumes on glass slides	89
Safety and efficacy of fruquintinib‐based therapy in patients with advanced or metastatic sarcoma	82
Intake of polyphenols from cereal foods and colorectal cancer risk in the Melbourne Collaborative Cohort Study	81
	72
Incidence and prognostic impact of U2AF1 mutations and other gene alterations in myelodysplastic neoplasms with isolated 20q deletion	71
Reasoning and causal inference regarding surgical options for patients with low‐grade gliomas using machine learning: A SEER‐based study	70
Efficacy and safety of anlotinib combined with PD‐1/PD‐L1 inhibitors as second‐line and subsequent therapy in advanced small‐cell lung cancer	69
Pancreatic adenosquamous carcinoma: A population level analysis of epidemiological trends and prognosis	68
Evaluating the impact of COVID‐19 on cancer declarations in Quebec, Canada	63
Deficiency of SR‐B1 reduced the tumor load of colitis‐induced or APC^min^/+‐induced colorectal cancer	61
Cancer and the family: Variations by sex and race/ethnicity	61
Cuproptosis gene‐related, neural network‐based prognosis prediction and drug‐target prediction for KIRC	59
Narrative Review of Patient Cancer Tissue–Derived Zebrafish Xenograft Models for Evaluating Drug Sensitivity as an Avatar Model for Clinical Application	59
Inflammatory geriatric nutritional risk index stratified the survival of older adults with cancer sarcopenia	58
Association of various RAS codon mutations and prognostic outcomes of patients with colorectal liver metastases after hepatectomy	56
Educational outcomes in siblings of childhood leukemia survivors: Factors associated with school difficulties and comparison with general population	55
Physical activity, polygenic risk score, and colorectal cancer risk	54

Impact of COVID ‐19 on Time to Treat Breast Cancer and Racial Disparities Among Women in the Military Health System From FY2	54
Distinct Clinicopathological Features of HER2 ‐Negative, HER2 ‐Low, and H	54
Risk factors for early mortality of lung cancer patients in France: A nationwide analysis	52
Exploration of the breast ductal carcinoma in situ signature and its prognostic implications	51
Effect modification of age and hypertension on cancer and prevalence of self‐reported stroke – A cross‐sectional study	50
Pulmonary lymphangitis carcinomatosis: A peculiar presentation clustering in MET‐amplified gastric cancer	49
The effect of body mass index on quality of life in modified single stoma cutaneous ureterostomy or ileal conduit after radical cystectomy	47
Cost‐effectiveness analysis of tumor‐infiltrating lymphocytes biomarkers guiding chemotherapy de‐escalation in early triple‐negative breast cancer	46
Outcomes and risk factors of SARS‐CoV‐2 omicron variant in B‐cell lymphoma patients following CD19 targeted CAR‐T therapy	45
Re‐irradiation in patients with progressive or recurrent brain metastases from extracranial solid tumors: A novel prognostic index	44
Family physicians' involvement in palliative cancer care	44
Associations among navigational support and health care utilization and costs in patients with advanced cancer: An analysis based on administrative health insurance data	44
Race‐specific prostate cancer outcomes in a cohort of military health care beneficiaries undergoing surgery: 1990–2017	43
Impact of skeletal muscle volume on patients with BCLC stage‐B hepatocellular carcinoma undergoing sorafenib therapy	43
Social Determinants of Health Predict Sleep–Wake Disturbances Among Patients Living With Primary Brain Tumors: A Cross‐Sectional Analysis	43
Mobilization of hematopoietic stem cells with lenograstim in multiple myeloma patients: Prospective multicenter observational study (KMM122)	43
Explorative Detection of Fractional Exhaled Nitric Oxide ( FeNO ) in Exhaled Breath of Patients With Breast Cancer	42
Estimating the overall survival benefit of adjuvant chemo‐endocrine therapy in women over age 50 with pT1‐2N0 early stage breast cancer and 21‐gene recurrence score ≥26: A Nation	42